Explore our informative 3-part video series, delving into the messaging pillars of Eviti Connect for Oncology. Learn how payers can...
According to the American Cancer Society, more than 18 million people in the U.S. have cancer, and many of them...
This white paper highlights 5 pressing challenges payers face as they attempt to enable the best outcomes for their members,...
Aside from non-melanoma skin cancer, prostate cancer is the most common cancer among men in the United States. For example,...
Oncology innovations and cancer care treatment are complex, exceeding an estimated $200 billion in 2020. As cancer research constantly develops new...
Learn how payers can reduce and manage the costs of cancer while driving positive outcomes for their members, their provider...
The burden of cancer and autoimmune diseases is heavy on patients, providers, and payers in the United States. Nearly 40...
NantHealth’s study data shows: Adoption of trastuzumab biosimilars in treatment of HER2-positive breast cancer is significant; does not appear to...
The COVID-19 pandemic has abruptly and fundamentally changed our lives, with specific, evolving impacts on healthcare. Our initial responses were...